Evidence map›Paper›PMID 25576062›Full record

ArticleDiabetes2015

Foregut exclusion disrupts intestinal glucose sensing and alters portal nutrient and hormonal milieu.

Atanu Pal, David B Rhoads, Ali Tavakkoli

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Measures of glucose homeostasis during and after duodenal exclusion using a duodenal-jejunal bypass liner in a normoglycemic, nonobese canine model.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2022
    Article
  4. Article
  5. Glucose transporters in the small intestine in health and disease.Pflugers Archiv : European journal of physiology · 2020
    Review
  6. Article
  7. Review
  8. Article
  9. Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Article
  10. Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut.JPEN. Journal of parenteral and enteral nutrition · 2018
    Review
  11. Customization of biliopancreatic limb length to modulate and sustain antidiabetic effect of gastric bypass surgery.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  12. Review
  13. Article
  14. Review
  15. Bile acids and bariatric surgery.Molecular aspects of medicine · 2017
    Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Atanu PalDepartment of Surgery, Brigham and Women's Hospital, Boston, MA Harvard Medical School, Boston, MA.
David B RhoadsHarvard Medical School, Boston, MA Pediatric Endocrine Unit, MassGeneral Hospital for Children, Boston, MA.
Ali TavakkoliDepartment of Surgery, Brigham and Women's Hospital, Boston, MA Harvard Medical School, Boston, MA atavakkoli@partners.org.
Brigham and Women's Hospital · USMaineGeneral Medical Center · US

Funding

Surgical Modulation of Intestinal Nutrient TransportR01DK084064 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI TAVAKKOLI, ALI · 2011 to 2015
$1.9M
NIDDK NIH HHS 1R01-DK-084064NIDDK NIH HHS R01 DK084064
6 · The paper itself

Abstract

The antidiabetes effects of Roux-en-Y gastric bypass (RYGB) are well-known, but the underlying mechanisms remain unclear. Isolating the proximal small intestine, and in particular its luminal glucose sensors, from the nutrient stream has been proposed as a critical change, but the pathways involved are unclear. In a rodent model, we tested the effects of isolating and then stimulating a segment of proximal intestine using glucose analogs to examine their impact on glucose absorption (Gabsorp) and hormone secretion after a glucose bolus into the distal jejunum. Analogs selective for sodium-glucose cotransporter (SGLT) family members and the sweet taste receptor were tested, and measurements of the portosystemic gradient were used to determine Gabsorp and hormone secretion, including GLP-1. Proximal intestinal isolation reduced Gabsorp and GLP-1 secretion. Stimulation of the glucose-sensing protein SGLT3 increased Gabsorp and GLP-1 secretion. These effects were abolished by vagotomy. Sweet taste receptor stimulation only increased GLP-1 secretion. This study suggests a novel role for SGLT3 in coordinating intestinal function, as reflected by the concomitant modulation of Gabsorp and GLP-1 secretion, with these effects being mediated by the vagus nerve. Our findings provide potential mechanistic insights into foregut exclusion in RYGB and identify SGLT3 as a possible antidiabetes therapeutic target.

Indexed as

AnimalsGlucoseGlucose Tolerance TestIntestinal MucosaIn Vitro TechniquesMaleRatsRats, Sprague-DawleyReal-Time Polymerase Chain ReactionSodium-Glucose Transporter 1Sodium-Glucose Transport ProteinsGlucoseSlc5a1 protein, ratSodium-Glucose Transporter 1Sodium-Glucose Transport Proteins

Identifiers

PMID25576062
PMCPMC4439569
OpenAlexW1985132605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.